![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/485 | |
A61K 9/20 | |||
A61P 25/04 |
(11) | Number of the document | 1404331 |
(13) | Kind of document | T |
(96) | European patent application number | 02744835.6 |
Date of filing the European patent application | 2002-07-03 | |
(97) | Date of publication of the European application | 2004-04-07 |
(45) | Date of publication and mention of the grant of the patent | 2007-10-31 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2002/021403 |
Date | 2002-07-03 |
(87) | Number | WO 2003/004033 |
Date | 2003-01-16 |
(30) | Number | Date | Country code |
303357 P | 2001-07-06 | US | |
329352 P | 2001-10-15 | US | |
329426 P | 2001-10-15 | US |
(72) |
BAICHWAL, Anand, R., US
KAO, Huai-Hung, US
MCCALL, Troy, W., US
|
(73) |
Penwest Pharmaceuticals Co.,
2981 Route 22, Patterson, NY 12563-9970,
US
|
(54) | SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE |
SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE |